LAVA Therapeutics NV
NASDAQ:LVTX
LAVA Therapeutics NV
NASDAQ:LVTX
Price:
1.29
USD
-0.77%
Market Closed
Market Cap:
33.9m
USD
Cash Flow Statement
Cash Flow Statement
LAVA Therapeutics NV
LAVA Therapeutics NV
Currency: USD
Millions
TTM
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(18)
|
(17)
|
(32)
|
(35)
|
(40)
|
(50)
|
(42)
|
(28)
|
(24)
|
(27)
|
|
| Depreciation & Amortization |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
2
|
3
|
4
|
4
|
5
|
5
|
5
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(2)
|
(4)
|
1
|
1
|
5
|
7
|
4
|
2
|
1
|
3
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
2
|
(12)
|
34
|
36
|
34
|
49
|
(3)
|
(7)
|
(5)
|
(5)
|
|
| Cash from Operating Activities |
(17)
N/A
|
(32)
-83%
|
4
N/A
|
3
-18%
|
(0)
N/A
|
7
N/A
|
(39)
N/A
|
(32)
+19%
|
(27)
+15%
|
(28)
-4%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
|
| Other Items |
7
|
14
|
10
|
14
|
11
|
(12)
|
(17)
|
(24)
|
(24)
|
(7)
|
|
| Cash from Investing Activities |
7
N/A
|
13
+96%
|
9
-31%
|
14
+46%
|
10
-24%
|
(13)
N/A
|
(18)
-35%
|
(25)
-39%
|
(24)
+0%
|
(7)
+71%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
0
-3%
|
0
-7%
|
(0)
N/A
|
(0)
-211%
|
(0)
-47%
|
(1)
-39%
|
(0)
+18%
|
(0)
+33%
|
(1)
-72%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
(5)
|
(9)
|
(4)
|
(2)
|
2
|
5
|
1
|
(1)
|
(1)
|
0
|
|
| Net Change in Cash |
(15)
N/A
|
(27)
-77%
|
9
N/A
|
15
+57%
|
12
-21%
|
(2)
N/A
|
(56)
-3 239%
|
(57)
-2%
|
(53)
+9%
|
(36)
+32%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(18)
N/A
|
(32)
-81%
|
3
N/A
|
3
-26%
|
(1)
N/A
|
6
N/A
|
(40)
N/A
|
(32)
+20%
|
(27)
+15%
|
(28)
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
